Logo

Rosetta Raises $8M in Private Placement

Oct 14, 2015 | staff reporter

NEW YORK (GenomeWeb) – Molecular diagnostics firm Rosetta Genomics announced today that it has raised $8 million in a private placement of stock and warrants.

According to the company, it has signed definite agreements with certain investors to sell 3,333,333 units at $2.40 apiece. Each unit consists of one ordinary share; a Series A warrant to purchase a half of an ordinary share at an exercise price of $2.75 per ordinary share five years from the sale's closing; and a partially pre-funded Series B warrant with an exercise price of New Israeli Shekel .6, which has been prepaid, plus $.0001.

Rosetta said that the Series B warrants are intended to reset the price of the units and will be exercisable for an aggregate number of ordinary shares based on certain conditions.

Aegis Capital acted as the exclusive placement agent in connection with the private placement.

During early morning trading on the Nasdaq Wednesday, shares of Rosetta were down $.24 at $2.31.

Filed under

Business News
Molecular Diagnostics
private financing
Rosetta Genomics
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.